Schrödinger, Inc (SDGR)

Etorro trading 970x250
Schrödinger, Inc (SDGR) Logo

About Schrödinger, Inc

Schrödinger, Inc. provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates through two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. has strategic collaborations with Thermo Fisher Scientific to extend the use of cryo-EM in connection within silico compound screening to accelerate drug discovery; and Bristol Myers Squibb Company to discover, develop, and commercialize therapeutics in multiple disease areas. The company was incorporated in 1990 and is headquartered in New York, New York. Address: 120 West 45th Street, New York, NY, United States, 10036

Schrödinger, Inc News and around…

Latest news about Schrödinger, Inc (SDGR) common stock and company :

Schrödinger to Participate in Five Upcoming Investor Conferences
22 Nov, 2021 FinancialContent

Schrödinger today announced it will participate in five upcoming investor conferences.

Expert Ratings For Schrodinger
19 Nov, 2021 FinancialContent

Over the past 3 months, 5 analysts have published their opinion on Schrodinger (NASDAQ:SDGR) stock. These analysts are typically ...

Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
19 Nov, 2021 FinancialContent

Upgrades Morgan Stanley upgraded the previous rating for EQT Corp (NYSE:EQT) from Equal-Weight to Overweight. For the ...

Schrödinger Awarded Grant to Accelerate Drug Discovery in Women’s Health
18 Nov, 2021 FinancialContent

Schrödinger today was awarded a grant to accelerate drug discovery in women’s health.

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
17 Nov, 2021 FinancialContent

Schrödinger today reported inducement grants under Nasdaq Listing Rule 5635(c)(4).

91 Biggest Movers From Yesterday
12 Nov, 2021 FinancialContent

Gainers NuZee, Inc. (NASDAQ: NUZE) shares jumped 164.5% to settle at $5.29 on Thursday. NuZee manufacturing partner, Cuvee Coffee, ...

Why Schrödinger Dived by Almost 12% Today
11 Nov, 2021 FinancialContent

The company plunges sharply into the red on the bottom line in its Q3, and misses analyst estimates.

BofA Downgrades Schrodinger On Slower Drug Discovery Ramp
11 Nov, 2021 FinancialContent

Schrodinger Inc (NASDAQ: SDGR) reported downbeat third-quarter results, mainly due to lower-than-expected drug discoveryrevenues, ...

Relative Strength Alert For Schrodinger
11 Nov, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

54 Stocks Moving In Thursday's Mid-Day Session
11 Nov, 2021 FinancialContent

Gainers Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares gained 42.6% to $9.68. Pioneer Power Solutions recently announced the ...

Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2021
11 Nov, 2021 FinancialContent

Upgrades Barrington Research upgraded the previous rating for Clear Channel Outdoor Holdings Inc (NYSE:CCO) from Market Perform to ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session
11 Nov, 2021 FinancialContent

Gainers ADMA Biologics (NASDAQ:ADMA) shares moved upwards by 11.42% to $1.56 during Thursday's pre-market session. ...

Schrödinger Shares Fall After Q3 Miss, Narrowed FY21 Revenue Outlook
11 Nov, 2021 FinancialContent

Schringer Inc(NASDAQ: SDGR)posted Q3 sales of $29.9 million, +16% Y/Y, missing the consensus of $31.58 ...

10 Biggest Price Target Changes For Thursday
11 Nov, 2021 FinancialContent

Mizuho raised Broadcom Inc. (NASDAQ: AVGO) price target from $545 to $600. Broadcom shares rose 0.7% to $552.70 in pre-market ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
11 Nov, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! We're ready to start off another busy day of trading with a breakdown of the biggest pre-market stock movers for Thursday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

28 Stocks Moving in Thursday's Pre-Market Session
11 Nov, 2021 FinancialContent

Gainers Fossil Group, Inc. (NASDAQ: FOSL) rose 33.8% to $18.52 in pre-market trading after the company reported ...

Schrodinger, inc (SDGR) Q3 2021 Earnings Call Transcript
11 Nov, 2021 FinancialContent

SDGR earnings call for the period ending September 30, 2021.

Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates
10 Nov, 2021 Yahoo! Finance

Schrodinger, Inc. (SDGR) delivered earnings and revenue surprises of -25.64% and -9.82%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Schrödinger Reports Third Quarter 2021 Financial Results and Provides Company Update
10 Nov, 2021 FinancialContent

Schrödinger today reported financial results for the third quarter of 2021 and provided a company update.

Was The Smart Money Right About Schrodinger, Inc. (SDGR)?
10 Nov, 2021 Yahoo! Finance

Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile […]

Schrödinger to Present at Jefferies London Healthcare Conference
09 Nov, 2021 FinancialContent

Schrödinger today announced that it will present at the Jefferies London Healthcare Conference.

Schrödinger to Present New Preclinical Data From Its MALT1 Inhibitor Program at ASH 2021 Annual Meeting
04 Nov, 2021 FinancialContent

Schrödinger today announced it will present new preclinical data from its MALT1 inhibitor program at the ASH 2021 Annual Meeting.

Earnings Preview: Schrodinger, Inc. (SDGR) Q3 Earnings Expected to Decline
03 Nov, 2021 Yahoo! Finance

Schrodinger, Inc. (SDGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Schrödinger to Host Conference Call to Discuss Third Quarter 2021 Financial Results
29 Oct, 2021 FinancialContent

Schrödinger today announced that it will report third quarter 2021 financial results on November 10, 2021.

Is Schrodinger, Inc. (SDGR) A Good Stock To Buy?
26 Oct, 2021 Yahoo! Finance

The Insider Monkey team has completed processing the quarterly 13F filings for the June quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as […]

Schrödinger (NASDAQ:SDGR) Is In A Strong Position To Grow Its Business
26 Oct, 2021 Yahoo! Finance

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Week In Review: China's Hansoh Signs Two siRNA Deals Worth $1.7 Billion
23 Oct, 2021 FinancialContent

Hansoh announced a $1.3 billion deal to develop three siRNA candidates from London's Silence Therapeutics. In the past week, Hansoh also revealed a $456 million deal with Korea's OliX Pharma for China rights to three other siRNA molecules.

Healthcare Cloud Computing Market Size Is Set To Surpass USD $79 Billion By 2027
21 Oct, 2021 FinancialContent
Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics, and Schrödinger Announce Collaboration to Discover Novel Orexin Receptor Agonists
18 Oct, 2021 FinancialContent

Today, Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics, and Schrödinger announced a collaboration to discover novel orexin receptor agonists.

Bet On Biopharma: Data, Digitization, Discovery
16 Oct, 2021 FinancialContent

The after-effects of pandemic-era policies will be with us for some time — with many supply chains still experiencing significant disruption. The worst of this “scarring” will heal. But the acceleration of tech adoption will be with us permanently.

Schrödinger, Inc (SDGR) is a NASDAQ Common Stock listed in , ,

970x250